Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
PUT
Automatic Data Processing
ADP
$107B
| $807K | ﹤0.01% |
9,000
-6,800
| -43% | -$570K |
|
4202
CALL
Standard BioTools
LAB
$307M
| $807K | ﹤0.01% |
100,000
-755,000
| -88% | -$5.45M |
|
|
4203
PUT
Standard BioTools
LAB
$307M
| $807K | ﹤0.01% |
100,000
-755,000
| -88% | -$5.45M |
|
|
ONC
4204
BeOne Medicines Ltd
ONC
$34B
| $807K | ﹤0.01% |
+27,529
| New | +$780K |
|
4205
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$5.8M
| $806K | ﹤0.01% |
2,370
-5,563
| -70% | -$2.28M |
|
|
INFN
4206
PUT
DELISTED
Infinera Corporation Common Stock
INFN
| $806K | ﹤0.01% |
50,200
+43,400
| +638% | +$665K |
|
4207
LendingTree
TREE
$475M
| $804K | ﹤0.01% |
8,222
+3,162
| +62% | +$247K |
|
|
MR
4208
DELISTED
Montage Resources Corporation Common Stock
MR
| $804K | ﹤0.01% |
37,215
-3,162
| -8% | -$51.7K |
|
|
BNY
4209
PUT
Bank of New York Mellon
BNY
$108B
| $803K | ﹤0.01% |
21,800
-15,400
| -41% | -$558K |
|
|
QIWI
4210
DELISTED
QIWI PLC
QIWI
| $803K | ﹤0.01% |
55,419
-1,262
| -2% | -$16.9K |
|
4211
CALL
GoDaddy
GDDY
$11.6B
| $802K | ﹤0.01% |
24,800
+1,700
| +7% | +$51.1K |
|
4212
CALL
Vanguard Total World Stock ETF
VT
$79.2B
| $802K | ﹤0.01% |
13,900
-3,200
| -19% | -$174K |
|
|
FL
4213
PUT
DELISTED
Foot Locker
FL
| $800K | ﹤0.01% |
12,400
-8,100
| -40% | -$526K |
|
4214
CALL
KB Home
KBH
$3.61B
| $800K | ﹤0.01% |
56,000
-2,300
| -4% | -$26.8K |
|
4215
US Physical Therapy
USPH
$1.18B
| $800K | ﹤0.01% |
16,077
+2,721
| +20% | +$135K |
|
4216
CALL
H&R Block
HRB
$5.82B
| $798K | ﹤0.01% |
30,200
-3,600
| -11% | -$113K |
|
4217
Kearny Financial
KRNY
$609M
| $798K | ﹤0.01% |
64,594
-15,196
| -19% | -$182K |
|
4218
CALL
Sanofi
SNY
$103B
| $795K | ﹤0.01% |
19,800
-7,200
| -27% | -$289K |
|
|
INSY
4219
CALL
DELISTED
Insys Therapeutics, Inc.
INSY
| $795K | ﹤0.01% |
+49,700
| New | +$944K |
|
4220
CALL
Icahn Enterprises
IEP
$5.01B
| $794K | ﹤0.01% |
12,600
+8,500
| +207% | +$489K |
|
4221
PUT
Autohome
ATHM
$2.65B
| $793K | ﹤0.01% |
28,400
+19,400
| +216% | +$510K |
|
4222
TherapeuticsMD
TXMD
$24M
| $793K | ﹤0.01% |
2,478
-3,461
| -58% | -$1.18M |
|
4223
Heritage Insurance Holdings
HRTG
$915M
| $792K | ﹤0.01% |
49,608
+3,597
| +8% | +$65.6K |
|
4224
NN Inc
NNBR
$301M
| $791K | ﹤0.01% |
57,792
+46,614
| +417% | +$578K |
|
4225
CALL
Microchip Technology
MCHP
$42.2B
| $790K | ﹤0.01% |
32,800
-16,000
| -33% | -$356K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.